자기 비즈 시장 보고서 : 유형별, 자기 코어별, 사이즈별, 용도별, 지역별(2025-2033년)

The global magnetic beads market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 10.29% during 2025-2033.

Magnetic beads are tiny particles of iron oxides used in molecular biology for easy and effective isolation of biomolecules. They provide a simple and reliable method of purifying plasmids, genomic and mitochondrial deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. They are widely utilized in next-generation sequencing (NGS), polymerase chain reaction (PCR), quantitative PCR (qPCR), droplet digital PCR (ddPCR) and other amplification and genotyping applications. They can also find applications as carriers of antigens, antibodies, and catalyzers for tissue-specific targeting and in magnetic resonance imaging (MRI, magnetic particle imaging, and nanomaterial-based catalysis worldwide.

Magnetic Beads Market Trends:

Molecular biology and nanotechnology-based analytical methods are nowadays employed as diagnostic tools for the rapid screening of coronavirus disease (COVID-19) with high accuracy and precision. This represents one of the major factors driving the need for magnetic beads across the globe. Apart from this, the rising preference for in-vitro diagnostic testing on account of their versatility and ability to provide quick results is impelling the market growth. Moreover, a significant increase in the human lifespan and aging of the baby boomer generation is catalyzing the demand for medicines and other studies targeting chronic diseases. This, in turn, is positively influencing the demand for magnetic beads to facilitate disease prevention and treatment methods and the generation of new protein products. Besides this, researchers are studying the efficacy of magnetic beads containing graphite carbon on removing color and organic substances in livestock wastewater. Such innovations are creating a positive influence on the usage of magnetic beads in the agriculture sector. Furthermore, rising investments in genetic and microbiology research activities are projected to provide a thrust to the market.

Key Market Segmentation:

Breakup by Type:

Cells

Pathogenic Microorganisms

Nucleic Acids

Peptide

Protein

Others

Breakup by Magnetic Core:

Superparamagnetic

Ferrimagnetic

Breakup by Size:

Less than 5 μm

5-20 μm

20-40 μm

40 μm and Above

Breakup by Application:

Next-Generation Sequencing

Biomolecules Separation and Purification

Molecular and Immunodiagnostics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced BioChemicals LLC, Bio-Rad Laboratories Inc., Calbiotech Inc, MagBio Genomics Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Vazyme Biotech Co. Ltd., and Xiamen Zeesan Biotech Co. Ltd.

Key Questions Answered in This Report

• 1. What was the size of the global magnetic beads market in 2024?
• 2. What is the expected growth rate of the global magnetic beads market during 2025-2033?
• 3. What are the key factors driving the global magnetic beads market?
• 4. What has been the impact of COVID-19 on the global magnetic beads market?
• 5. What is the breakup of the global magnetic beads market based on the type?
• 6. What is the breakup of the global magnetic beads market based on the magnetic core?
• 7. What is the breakup of the global magnetic beads market based on the size?
• 8. What is the breakup of the global magnetic beads market based on the application?
• 9. What are the key regions in the global magnetic beads market?
• 10. Who are the key players/companies in the global magnetic beads market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Magnetic Beads Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Cells
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Pathogenic Microorganisms
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Nucleic Acids
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Peptide
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Protein
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Magnetic Core

• 7.1 Superparamagnetic
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ferrimagnetic
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Size

• 8.1 Less than 5 μm
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 5-20 μm
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 20-40 μm
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 40 μm and Above
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Application

• 9.1 Next-Generation Sequencing
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Biomolecules Separation and Purification
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Molecular and Immunodiagnostics
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Advanced BioChemicals LLC
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Bio-Rad Laboratories Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Calbiotech Inc
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 MagBio Genomics Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Merck KGaA
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 New England Biolabs
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Promega Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Qiagen N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Thermo Fisher Scientific Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Vazyme Biotech Co. Ltd.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Xiamen Zeesan Biotech Co. Ltd.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio